Average Co-Inventor Count = 9.70
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ariad Pharmaceuticals, Inc. (10 from 69 patents)
2. Ucb S.a. (1 from 119 patents)
3. Cubist Pharmaceuticals, Incorporated (1 from 59 patents)
4. Cubist Pharmacueticals, Inc. (1 from 1 patent)
5. Araid Gene Therapeutics, Inc. (1 from 1 patent)
6. Ucb, S.a./n.v. (1 from 1 patent)
7. Merck Sharp + Dohme Corp. (2,405 patents)
8. Hydra Biosciences, Inc. (49 patents)
15 patents:
1. 9278971 - Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors
2. 9273077 - Phosphorus derivatives as kinase inhibitors
3. 9193729 - Inhibiting transient receptor potential ion channel TRPA1
4. 9090561 - Acetylenic heteroaryl compounds
5. 9029533 - Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors
6. 9012462 - Phosphorous derivatives as kinase inhibitors
7. 8809314 - Cephalosporin compound
8. 8778942 - Substituted acetylenic imidazo[1,2-A]pyrazine compounds as kinase inhibitors
9. 8470851 - Substituted acetylenic imidazo[1,2-A]pyridine compounds as kinase inhibitors
10. 8461167 - Acetylenic heteroaryl compounds
11. 8278307 - Monocyclic Heteroaryl compounds
12. 8114874 - Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors
13. 7432277 - Phosphorus-containing macrocycles
14. 6936633 - Pyrrolidinone derivatives
15. 6727275 - Pyrrolidinone derivatives